Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1874 (LINC01874) is a type of long intergenic non-coding RNA (lincRNA), which refers to RNA transcripts longer than 200 nucleotides that do not overlap protein-coding genes and do not code for proteins. LincRNAs, including LINC01874, generally function in the regulation of gene expression, often acting through modulation of chromatin structure, transcription, or by acting as molecular sponges for microRNAs. There is no documented evidence that LINC01874 acts as a receptor, enzyme, transporter, or a conventional drug target, nor are there specific reports of its involvement in recognized biological or pathological roles. While lincRNAs as a class can be deregulated in cancer and other diseases, no data supports LINC01874 as a therapeutic target or disease-specific biomarker at present.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1874 (LINC01874).